Gastric mucosal fibrosis: A novel explanation for dyspepsia

Medical Hypotheses

Volumn 61, Issue 5-6, 2003, Pages 513-516

  Khurana, V ^a,b   Singh, T ^a  

^a OVERTON BROOKS VA MEDICAL CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC GASTRITIS; DYSPEPSIA; ERADICATION THERAPY; FIBROSIS; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; HYPOTHESIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; STOMACH MUCOSA; ULTRASTRUCTURE;

HELICOBACTER; HELICOBACTER PYLORI;

EID: 0242551093     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-9877(03)00203-2     Document Type: Article

References (30)

1. Talley N. J., Axon A., Bytzer P., Holtmann G., Lam S. K., Van Zanten S. Management of uninvestigated and functional dyspepsia: a working party report for the world congresses of gastroenterology 1998. Aliment Pharmacol Ther 1999; 13: 1135-1148.
2. Knill-Jones R. P. Geographical differences in the prevalence of dyspepsia. Scand J Gastroenterol Suppl 1991; 182: 17-24.
3. Talley N. J., Stanghellini V., Heading R. C., Koch K. L., Malagelada J. R., Tytgat G. N. Functional gastroduodenal disorders. Gut 1999; 45(suppl. 2): II37-II42.
4. Talley N. J., Silverstein M. D., Agreus L., Nyren O., Sonnenberg A., Holtmann G. AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology 1998; 114: 582-595.
5. Danesh J., Lawrence M., Murphy M., Roberts S., Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000; 160: 1192-1198.
6. Bernersen B., Johnsen R., Bostad L., Straume B., Sommer A. I., Burhol P. G. Is Helicobacter pylori the cause of dyspepsia? BMJ 1992; 304: 1276-1279.
7. Plebani M., Basso D., Cassaro M., Brigato L., Scrigner M., Toma A., Di Mario F., Rugge M. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996; 91: 954-958.
8. Ganga-Zandzou P. S., Michaud L., Vincent P., Husson M. O., Wizla-Derambure N., Delassalle E. M., Turck D., Gottrand F. Natural outcome of Helicobacter pylori infection in asymptomatic children: a two-year follow-up study. Pediatrics 1999; 104: 216-221.
9. Hermanns W., Kregel K., Breuer W., Lechner J. Helicobacter-like organisms: histopathological examination of gastric biopsies from dogs and cats. J Comp Pathol 1995; 112: 307-318.
10. Hui P. K., Chan W. Y., Cheung P. S., Chan J. K., Ng C. S. Pathologic changes of gastric mucosa colonized by Helicobacter pylori. Hum Pathol 1992; 23: 548-556.
11. Lloyd K. D. HT. Regulation of gastric acid secretion. In: L. C. J. Johnson, M. J. Jackson, E. D. Jacobson, J. H. Walsh (eds). Physiology of the Gastrointestinal Tract; vol. 2. New York: Raven Press, 1994: 935-940.
12. Hersey S. J., Sachs G. Gastric acid secretion. Physiol Rev 1995; 75: 155-189.
13. Feldman M. Gastric secretion: normal and abnormal. In: M. S. M. H. Feldman, B. F. Scharschmidt (eds). Gastrointestinal and Liver Disease; 6th Edn. London: W.B. Saunders Company, 1998: 595.
14. Jacobson E. D., Eisenberg M., Swan K. G. Effects of histamine on gastric blood flow in conscious dogs. Gastroenterology 1968; 54(suppl.): 713-714.
15. Guth P. H., Baumann H., Grossman M. I., Aures D., Elashoff J. Measurement of gastric mucosal blood flow in man. Gastroenterology 1978; 74: 831-834.
16. Main I. H., Whittle B. J. A study of the vascular and acid-secretory responses of the rat gastric mucosa to histamine. J Physiol 1976; 257: 407-418.
17. Zalewsky C. A., Moody F. G. Stereological analysis of the parietal cell during acid secretion and inhibition. Gastroenterology 1977; 73: 66-74.
18. Helander H. F. Physiology and pharmacology of the parietal cell. Baillieres Clin Gastroenterol 1988; 2: 539-554.
19. Brandt L. S., Smithline A. E. Ischaemic lesions of the bowel. In: M. S. Feldman, M. H. Sleisenger, B. F. Scharschmidt (eds). Gastrointestinal and Liver Diseases; vol. 2. London: W.B. Saunders Company, 1998: 2020.
20. Jones R. S. Acute abdomen. In: M. C. Townsend (ed). Sabiston Textbook of Surgery, 16th Edn. London: W.B. Saunders Company, 2001: 802-804.
21. Laine L., Schoenfeld P., Fennerty M. B. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 134: 361-369.
22. Veldhuyzen van Zanten S. J., Talley N. J., Blum A. L., Bolling-Sternevald E., Sundin M., Junghard O. Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut 2002; 50(suppl. 4): iv26-iv30, discussion iv31-2.
23. Dobrilla G., Comberlato M., Steele A., Vallaperta P. Drug treatment of functional dyspepsia. A meta-analysis of randomized controlled clinical trials. J Clin Gastroenterol 1989; 11: 169-177.
24. Finney J. S., Kinnersley N., Hughes M., O'Bryan-Tear C. G., Lothian J. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998; 26: 312-320.
25. Redstone H. A., Barrowman N., Veldhuyzen Van Zanten S. J. H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia: a meta-analysis of randomized controlled clinical trials. Aliment Pharmacol Ther 2001; 15: 1291-1299.
26. Nielsen H., Madsen P. E., Christiansen L. A. The parietal cells in duodenal ulcer patients. A quantitative ultrastructural study before and during treatment with cimetidine. Scand J Gastroenterol 1980; 15: 793-797.
27. Karasawa H., Tani N., Miwa T. The effect of omeprazole on ultrastructural changes in gastric parietal cells. Gastroenterol Jpn 1988; 23: 1-8.
28. Kato S., Fujii T., Nakano K., Naganuma H., Nakagawa H. The effects of omeprazole on the ultrastructure of gastric parietal cells. J Pediatr Gastroenterol Nutr 1994; 19: 91-96.
29. Synnerstad I., Holm L. Omeprazole induces high intraglandular pressure in the rat gastric mucosa. Gastroenterology 1997; 112: 1221-1230.
30. Poole P. Pantoprazole. Am J Health Syst Pharm 2001; 58: 999-1008.